We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$317M
AUM Growth
-$63.2M
Cap. Flow
-$56.2M
Cap. Flow %
-17.75%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AI icon
C3.ai
AI
+$32.3M
2
PMVP icon
PMV Pharmaceuticals
PMVP
+$16.7M
3
STIM icon
Neuronetics
STIM
+$6.15M
4
HIND
Vyome Holdings
HIND
+$1.07M

Sector Composition

Rank Sector Weight
1 Healthcare 68.22%
2 Technology 17.1%
3 Consumer Discretionary 14.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$59.2M
$170M 53.57%
4,969,911
-500,000
-9% -$16.7M
AI icon
2
C3.ai
AI
$1.4B
$54.2M 17.1%
866,774
-520,000
-37% -$32.3M
REAL icon
3
The RealReal
REAL
$1.41B
$46.5M 14.68%
2,354,080
– –
GKOS icon
4
Glaukos
GKOS
$8.83B
$29.4M 9.27%
346,364
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6.52M 2.06%
25,497
– –
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.49M 1.73%
1,404,515
– –
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$2.74M 0.86%
67,841
– –
VERO
8
DELISTED
Venus Concept
VERO
$2.05M 0.65%
3,992
– –
XENE icon
9
Xenon Pharmaceuticals
XENE
$6.29B
$148K 0.05%
8,293
– –
DARE icon
10
Dare Bioscience
DARE
$19M
$95K 0.03%
4,197
– –
HIND
11
Vyome Holdings
HIND
$13.9M
– –
0
– -$1.07M
STIM icon
12
Neuronetics
STIM
$124M
– –
-497,158
Closed -$6.15M

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q2 2021 Portfolio in Review

As of Q2 2021, InterWest Venture Management held 12 positions worth $317M, down 17% from $380M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $56.2M in Q2 2021, closing 1 position and reducing 2 holdings. Its most notable exit was Neuronetics, an estimated $6.15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 62% a quarter earlier, followed by Technology and Consumer Discretionary.

  • InterWest Venture Management's biggest Q2 2021 reduction was C3.ai, cutting an estimated $32.3M.
  • InterWest Venture Management fully exited Neuronetics in Q2 2021, selling an estimated $6.15M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $317M portfolio in Q2 2021.
  • InterWest Venture Management opened 0 new positions and closed 1 in Q2 2021.
  • InterWest Venture Management's portfolio value fell 17% quarter-over-quarter to $317M.

Based on InterWest Venture Management's 13F filing for Q2 2021, filed 26 Jul 2021.